Phadia US Inc. Joins AANMA in Calling for National Institutes of Health (NIH) Guidelines-Level Care for All People with Asthma

Published: May 06, 2009

PORTAGE, Mich.--(BUSINESS WIRE)--Phadia US Inc, the world leader in in vitro allergy diagnostics and manufacturer of ImmunoCAP Specific IgE blood testing, today announced its support of Allergy & Asthma Network Mothers of Asthmatics (AANMA) in calling for national asthma guidelines-level care for all people with asthma.

Back to news